Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
5
6
7
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
Federles Master Tutorial On Abdominal Imaging
2020-06-29 - 2020-07-01    
All Day
The course is designed to provide the tools for participants to enhance abdominal imaging interpretation skills utilizing the latest imaging technologies. Time: 1:00 pm - [...]
IASTEM - 864th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-07-01 - 2020-07-02    
All Day
IASTEM - 864th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 3rd - 4th July, 2020 at Hamburg, Germany . [...]
International Conference On Medical & Health Science
2020-07-02 - 2020-07-03    
All Day
ICMHS is being organized by Researchfora. The aim of the conference is to provide the platform for Students, Doctors, Researchers and Academicians to share the [...]
Mental Health, Addiction, And Legal Aspects Of End-Of-Life Care CME Cruise
2020-07-03 - 2020-07-10    
All Day
Mental Health, Addiction Medicine, and Legal Aspects of End-of-Life Care CME Cruise Conference. 7-Night Cruise to Alaska from Seattle, Washington on Celebrity Cruises Celebrity Solstice. [...]
ISER- 843rd International Conference On Science, Health And Medicine ICSHM
2020-07-03 - 2020-07-04    
All Day
ISER- 843rd International Conference on Science, Health and Medicine (ICSHM) is a prestigious event organized with a motivation to provide an excellent international platform for the academicians, [...]
04 Jul
2020-07-04    
12:00 am
ICRAMMHS is to bring together innovative academics and industrial experts in the field of Medical, Medicine and Health Sciences to a common forum. All the [...]
6th Annual Formulation And Drug Delivery Congress
2020-07-08 - 2020-07-09    
All Day
Meet and learn from experts in the pharmaceutical sciences community to address critical strategic developments and technical innovation in formulation, drug delivery and manufacturing of [...]
7th Global Conference On Pharma Industry And Medical Devices
2020-07-08 - 2020-07-09    
All Day
The Global Conference on Pharma Industry and Medical Devices GCPIMD is to bring together innovative academics and industrial experts in the field of Pharmacy and [...]
IASTEM - 868th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-07-09 - 2020-07-10    
All Day
IASTEM - 868th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 9th - 10th July, 2020 at Amsterdam, Netherlands . [...]
2nd Annual Congress On Antibiotics, Bacterial Infections & Antimicrobial Resistance
2020-07-09 - 2020-07-10    
All Day
EURO ANTIBIOTICS 2020 invites all the participants from all over the world to attend 2nd Annual Congress Antibiotics, Bacterial infections & Antimicrobial Resistance to be [...]
Events on 2020-06-29
Events on 2020-07-02
Latest News

Factors Predicting Poor Locoregional Control in Tongue Cancer

In patients with pT1-2N0 oral tongue squamous cell carcinoma undergoing partial glossectomy and elective neck dissection, inferior locoregional control (LRC) was associated with depth of invasion, lymphovascular space invasion, and positive glossectomy specimen margins. These retrospective findings, presented at the 2024 ASTRO Multidisciplinary Head and Neck Cancers Symposium, remained significant even in cases with final negative tumor bed margins.At a median follow-up of 45.6 months, the all-comer patient population exhibited 3-year locoregional control (LRC) and overall survival (OS) rates of 88.0% and 92.5%, respectively. Among patients with pT1 disease, these rates were 92.0% and 95.2%, while in those with pT2 disease, the rates were 85.0% and 90.5%.

However, during the multivariate analysis, individuals with positive glossectomy margins exhibited poorer locoregional control (HR, 6.66; 95% CI, 1.60-27.78; P = .009). Lymphovascular space invasion (HR, 6.90; 95% CI, 1.42-33.65; P = .02) and depth of invasion (HR, 1.31; 95% CI, 1.06-1.63; P = .01) were also correlated with diminished locoregional control.

The lead study author, Michael Modzelewski, MD, along with the co-investigators, stated in a poster presented at the meeting, “Patients with these risk factors may be considered for adjuvant radiotherapy to optimize disease control.”

Individuals with early-stage tongue squamous cell carcinoma typically do not undergo adjuvant radiation due to their low recurrence risk. After surgery, the status of the primary glossectomy specimen margin has been observed to have a stronger correlation with local recurrence than the status of additional tumor bed margins, as stated by the authors.

The investigators aimed to identify the pathological factors associated with locoregional recurrence in patients with early-stage tongue squamous cell carcinoma who underwent surgery alone. Additionally, they explored the impact of a positive glossectomy specimen margin on disease control concerning final negative tumor bed margins.

The research included 110 patients diagnosed with pT1-2N0 oral tongue squamous cancer, adhering to the American Joint Committee on Cancer (AJCC) 8th edition criteria. These individuals underwent partial glossectomy and elective dissection from 2015 to 2021, excluding adjuvant radiation. Pathology reports were examined for factors such as tumor size, depth of invasion, glossectomy specimen margin, final tumor bed margin status, and perineural or lymphovascular space invasion. Individuals with positive final margins or a history of head and neck radiation were excluded.

The Kaplan-Meier method was employed to estimate locoregional control (LRC) and overall survival (OS), with a Cox proportional hazards model identifying prognostic factors for LRC in multivariate analysis.

Concerning baseline characteristics, the median age was 52 years, with the majority being male (54.5%) and having pT2 stage disease (58.2%). There were 33 lymph nodes dissected on average, and the median tumor size measured 16 mm, with a depth of invasion reaching 5 mm.

The majority of patients did not exhibit perineural invasion (84.7%), while 3.6% had lymphovascular space invasion. Positive glossectomy specimen margins were observed in 8.2% of cases.

Further findings revealed that among patients with positive glossectomy specimen margins and those without, the 3-year locoregional control (LRC) rates were 66.7% and 89.5%, respectively. Similarly, the rates were 0.0% for individuals with lymphovascular space invasion and 89.4% for those without. Among the 8 patients experiencing regional failure, 5 had recurrence in the ipsilateral neck alone (62.5%), 2 in the bilateral neck (25.0%), and 1 with isolated contralateral neck recurrence (12.5%).